Poorly-performed osteoporosis market
Bisphosphonate(BP) drugs, osteoporosis treatments that are known to have particular administration, have recorded poor performances.
On the other hand, SERM-type drugs have become the only drugs which showed potentials in the falling osteoporosis market. The uptrend of ‘Evista,’ the first SERM-t...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
